Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 123.87% institutional investors, 1.80% insiders. Vanguard group is the largest institutional shareholder, holding 11.35% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.03% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 123.87% | 1.80% | -25.67% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.09M | 11.35% | $464.74M |
| Fmr | 8.93M | 11.15% | $456.49M |
| Blackrock funding, inc. /de | 7.52M | 9.38% | $384.25M |
| Wellington management group llp | 6.95M | 8.68% | $355.38M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Driehaus capital management | 6.14M | 7.67% | $313.99M |
| Price t rowe associates inc /md/ | 5.41M | 6.76% | $276.84M |
| Ecor1 capital | 4.29M | 5.35% | $219.25M |
| Farallon capital management | 4.08M | 5.09% | $208.36M |
| State street | 2.99M | 3.73% | $152.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 141.00K | 9.64% | $7.21M |
| Ecor1 capital | 4.29M | 8.29% | $219.25M |
| Acuta capital partners | 122.90K | 6.32% | $6.28B |
| Bioimpact capital | 617.03K | 4.48% | $31.55M |
| First light asset management | 885.45K | 4.33% | $45.27M |
| First turn management | 453.38K | 4.15% | $23.18M |
| Stempoint capital lp | 317.06K | 4.05% | $16.21M |
| Siren | 1.61M | 3.64% | $82.30M |
| Ikarian capital | 516.43K | 3.59% | $26.41M |
| Paradigm biocapital advisors lp | 1.91M | 3.40% | $97.70M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.93M | 0.03% | 4.47M |
| Farallon capital management | 4.08M | 1.06% | 2.91M |
| Vanguard group | 9.09M | 0.01% | 2.80M |
| Wellington management group llp | 6.95M | 0.07% | 2.49M |
| Blackrock funding, inc. /de | 7.52M | 0.01% | 965.25K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 1.91M | 3.40% | -605.92K |
| Perceptive advisors | 184.53K | 0.26% | -540.17K |
| Dimensional fund advisors lp | - | - | -392.20K |
| Laurion capital management lp | - | - | -350.77K |
| Vivo capital | - | - | -350.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Segall bryant & hamill | 150.40K | 0.11% | 150.40K | $7.69M |
| Soleus capital management | 85.00K | 0.27% | 85.00K | $4.35M |
| Woodline partners lp | 50.00K | 0.02% | 50.00K | $2.56M |
| Schroder investment management group | 29.36K | 0.00% | 29.36K | $1.49M |
| Aquatic capital management | 27.71K | 0.04% | 27.71K | $1.42M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -8.00 |
| Cibc private wealth group | -15.00 |
| Householder group estate & retirement specialist | -25.00 |
| Newedge advisors | -30.00 |
| Innealta capital | -36.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 243 | 2.53% | 99,207,040 | 17.39% | 123 | 1.11% | 144 | 18.03% | 66 | -12.00% |
| Sep 30, 2024 | 235 | -1.67% | 84,500,757 | 2.47% | 105 | 0.81% | 121 | -20.91% | 74 | 37.04% |
| Jun 30, 2024 | 239 | 8.64% | 82,467,822 | 2.56% | 114 | 0.92% | 153 | 20.47% | 54 | -3.57% |
| Mar 31, 2024 | 220 | 11.68% | 80,408,468 | 13.80% | 111 | 0.75% | 127 | 13.39% | 56 | - |
| Dec 31, 2023 | 197 | - | 70,656,199 | 3.13% | 121 | 0.84% | 112 | -16.42% | 56 | 86.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.82M | 3.03% | 2.23K |
| iShares Russell 2000 ETF | 2.40M | 2.58% | -20.84K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| Vanguard Health Care Inv | 2.28M | 2.46% | 1.32M |
| Vanguard Small Cap Index | 2.25M | 2.42% | 1.83K |
| US Small-Cap Growth II Equity Comp | 2.14M | 2.31% | 123.15K |
| T. Rowe Price New Horizons | 2.14M | 2.30% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.42M | 1.53% | 2.04K |
| T. Rowe Price Integrated US SmCapGrEq | 1.28M | 1.38% | 722.20K |
| Vanguard Small Cap Growth Index Inv | 1.26M | 1.36% | -6.56K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $4.42K |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $81.60K |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | $232.39K |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | $12.57K |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | $187.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 10 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 11 |
| 2024 Q2 | - | 11 |
| 2024 Q1 | - | 14 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools